Express Scripts Holding Company (ESRX)

92.33
3.47 3.62
NASDAQ
Prev Close 95.80
Open 95.57
Day Low/High 92.11 / 95.87
52 Wk Low/High 66.93 / 101.73
Volume 31.61M
Exchange NASDAQ
Div & Yield N.A. (N.A)
Stocks Trade at Intraday Record Highs as Consumer Staples Lead Gainers

Stocks Trade at Intraday Record Highs as Consumer Staples Lead Gainers

Stocks move higher on Tuesday, looking to reverse the previous session's losses as investors look toward the kickoff to the earnings season at the end of the week.

CVS Health, Express Scripts, Walgreens Shares Crash on Amazon Drugs Threat

CVS Health, Express Scripts, Walgreens Shares Crash on Amazon Drugs Threat

Amazon has already destroyed mall anchors; analysts expect pharmacy benefit managers to be next.

Express Scripts Inks Deal to Buy EviCore for $3.6 Billion

Express Scripts Inks Deal to Buy EviCore for $3.6 Billion

Express Scripts expects the deal will grow earnings in the first full year of operation.

Stocks Are Saying They're Tired

If the market appears too good to be true, it probably is.

The New #6 Most Shorted Nasdaq 100 Component: Express Scripts Holding

The New #6 Most Shorted Nasdaq 100 Component: Express Scripts Holding

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Stock Futures Rise on Earnings Beats From AMD and Boeing

Stock Futures Rise on Earnings Beats From AMD and Boeing

Stock futures are higher.

The Dow Binges on Earnings

The Dow Binges on Earnings

Get ready for another heavy earnings slate

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens

U.S. stock futures turn higher on Tuesday following earnings from Alphabet.

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

Wall Street's first glimpse at the second quarter.

What's Fueling This Rally: Cramer's 'Mad Money' Recap (Wednesday 7/12/17)

What's Fueling This Rally: Cramer's 'Mad Money' Recap (Wednesday 7/12/17)

Jim Cramer points out the positive actions that show how rallies can come together based on fundamentals, not just sentiment.

Starbucks, STMicroelectronics, Athenex : 'Mad Money' Lightning Round

Starbucks, STMicroelectronics, Athenex : 'Mad Money' Lightning Round

Jim Cramer notes Starbucks is improving its mobile ordering and pay experience.

Here's Why Amazon Could Feast on the Remaining Carcass of Rite Aid After Failed Walgreens Merger

Here's Why Amazon Could Feast on the Remaining Carcass of Rite Aid After Failed Walgreens Merger

One Wall Street firm thinks it's a real possibility.

Walgreens Says It Would Consider a Partnership With Amazon If It Wants to Do the Pharmacy Thing

Walgreens Says It Would Consider a Partnership With Amazon If It Wants to Do the Pharmacy Thing

But, Walgreens says Amazon probably won't pursue this venture.

Activist Turns Up the Heat on Deckers; Senate Postpones Healthcare Vote -- ICYMI Tuesday

Activist Turns Up the Heat on Deckers; Senate Postpones Healthcare Vote -- ICYMI Tuesday

Here's what you need to know now.

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.

We Are In a Rare Moment, Explains Jim Cramer

We Are In a Rare Moment, Explains Jim Cramer

Everything you must know about the market right now is here.

Stay Focused, People!: Cramer's 'Mad Money' Recap (Thursday, 6/8/17)

Stay Focused, People!: Cramer's 'Mad Money' Recap (Thursday, 6/8/17)

Jim Cramer says the story is less about Comey vs. Trump than it is about Nvidia vs. Nordstrom.

Why Jim Cramer Is Bringing Back His "CANDIES" Market Acronym

Why Jim Cramer Is Bringing Back His "CANDIES" Market Acronym

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is bringing back his "CANDIES" market acronym.

Cramer: Worried About That Weak FANG? Try Some Old CANDIES

Cramer: Worried About That Weak FANG? Try Some Old CANDIES

I was pleasantly surprised to see that the candies are still crushing it.

Express Scripts Launches Program Aimed to Curb Opioid Addiction Epidemic

Express Scripts Launches Program Aimed to Curb Opioid Addiction Epidemic

The CDC estimates that 90 people a day die from opioid overdoses.

Wall Street Backs Off of Records After London Terror Attack, Crude Oil Drop

Wall Street Backs Off of Records After London Terror Attack, Crude Oil Drop

Wall Street wasn't able to extend a record-breaking streak into a third session on Monday after a terror attack in London.

Closing Bell: Stocks Snap Two-Day Winning Streak; Apple to Add Amazon prime to Apple TV

Closing Bell: Stocks Snap Two-Day Winning Streak; Apple to Add Amazon prime to Apple TV

Wall Street couldn't extend a record-breaking steak into a third session following the weekend terror attack in London.

Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication

Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication

Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant.

Behind the War Between Health Insurers and Pharmacy Benefit Managers

Behind the War Between Health Insurers and Pharmacy Benefit Managers

More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.

Two More Stock Picks From Hedge Fund Leaders at SALT

Two More Stock Picks From Hedge Fund Leaders at SALT

Kynikos Associates' James Chanos, famous for his shorting campaign at Enron, on Thursday presented a short campaign.

Hertz Shareholders Could Feel Pain Today as Company Misses Earnings

Hertz Shareholders Could Feel Pain Today as Company Misses Earnings

Hertz blames bad year over year comparisons for its earnings miss.

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.